Ophthalmology specialist Iveric snapped up by Astellas for $5.9 billion
The Japanese pharmaceutical giant Astellas Pharma has taken over the U.S. company Iveric Bio in a $5.9 billion deal to get hold of its ophthalmology-focused pipeline.
Archives for May 3, 2023
ValGenesis launches end-to-end cleaning validation software
The company makes available its Process Manager software, which digitizes the end-to-end risk-based cleaning validation lifecycle.
Interview: The importance of digital biomarkers in clinical research
Rich Christie is chief medical officer at AiCure LLC. He is a firm believer in digtal biomarkers and the audio and visual biomarkers that can be captured through a front-facing camera. OSP inteviewed him to find about more about the changing landscape...
Scorpion Therapeutics announces first patient dosed in clinical trial for the treatment of breast cancer and solid tumors
Scorpion Therapeutics, a clinical-stage oncology company, has announced that the first patient has been dosed in a phase 1/2 clinical trial of STX-478, its treatment for breast cancer and other solid tumors.